Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial

BACKGROUND & AIMS: FALCON 1 was a phase IIb study of pegbelfermin in patients with non-alcoholic steatohepatitis (NASH) and stage 3 fibrosis. This FALCON 1 post hoc analysis aimed to further assess the effect of pegbelfermin on NASH-related biomarkers, correlations between histological assessmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Elizabeth A., Minnich, Anne, Sanyal, Arun J., Loomba, Rohit, Du, Shuyan, Schwarz, John, Ehman, Richard L., Karsdal, Morten, Leeming, Diana J., Cizza, Giovanni, Charles, Edgar D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971179/
https://www.ncbi.nlm.nih.gov/pubmed/36866389
http://dx.doi.org/10.1016/j.jhepr.2022.100661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971179/
https://www.ncbi.nlm.nih.gov/pubmed/36866389
http://dx.doi.org/10.1016/j.jhepr.2022.100661

Ejemplares similares